Earnings Alerts

Japan Tobacco (2914) Earnings: Operating Income Forecast Boosted but Still Misses Estimates

  • FY Operating Income Forecast: 660.00 billion yen (previously saw 648.00 billion yen, missed the estimate of 712.81 billion yen)
  • FY Net Income Forecast: 475.00 billion yen (previously saw 455.00 billion yen, missed the estimate of 504.97 billion yen)
  • FY Net Sales Forecast: 3.11 trillion yen (previously saw 3.02 trillion yen, met estimated 3.04 trillion yen)
  • Dividend Forecast: Remains 194.00 yen (estimate was 205.70 yen)

First Half Results

  • Tobacco Adjusted Operating Profit: 472.10 billion yen
  • Pharmaceuticals Adjusted Operating Profit: 4.00 billion yen
  • Processed Food Adjusted Operating Profit: 4.37 billion yen
  • Tobacco External Revenue: 1.45 trillion yen
  • Pharmaceuticals External Revenue: 44.06 billion yen
  • Processed Food External Revenue: 73.82 billion yen

Second Quarter Results

  • Net Income: 147.91 billion yen
  • Net Sales: 829.56 billion yen (estimate was 796.57 billion yen)
  • Operating Income: 216.84 billion yen (estimate was 215.72 billion yen)

Analyst Recommendations

  • Latest Analysts’ Ratings: 5 buys, 7 holds, 1 sell

A look at Japan Tobacco Smart Scores

FactorScoreMagnitude
Value3
Dividend5
Growth3
Resilience3
Momentum5
OVERALL SMART SCORE3.8

Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma

Analysts predict that Japan Tobacco, Inc. is strategically positioned for long-term success based on the Smartkarma Smart Scores. While the company demonstrates strength in dividends and momentum with top scores of 5 each, it also shows solid performance in value, growth, and resilience with scores of 3 in each category. This balanced scoring suggests that Japan Tobacco is an attractive investment opportunity for those seeking both growth potential and stability in the tobacco industry.

Japan Tobacco, Inc. operates as a tobacco product company with an international presence in the manufacturing, marketing, and selling of cigarettes and other tobacco products. In addition to its core business, the company is involved in pharmaceutical and food ventures. With consistently high scores in dividends and momentum, Japan Tobacco is well-positioned to navigate the challenges of the industry and deliver sustainable returns to its investors in the long run.


Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.


 

πŸ’‘ Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • βœ“ Unlimited Research Summaries
  • βœ“ Personalised Alerts
  • βœ“ Custom Watchlists
  • βœ“ Company Analytics and News
  • βœ“ Events & Webinars